Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis

BACKGROUND: In muscle-invasive bladder cancer (MIBC), neoadjuvant chemotherapy (NAC) combined with radical cystectomy (RC) is critical in reducing disease recurrence, with GC (gemcitabine and cisplatin) being one of the most commonly used NACs. Different GC schedules have been used, but the best neo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Lanpeng, Chen, Chaohu, Cheng, Hui, Ding, Hui, Tian, Junqiang, Wang, Hanzhang, Wang, Zhiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626748/
https://www.ncbi.nlm.nih.gov/pubmed/37932689
http://dx.doi.org/10.1186/s12885-023-11572-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626748/
https://www.ncbi.nlm.nih.gov/pubmed/37932689
http://dx.doi.org/10.1186/s12885-023-11572-0

Ejemplares similares